#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA707653	F	Ability to reverse the multidrug resistance (MDR) of mouse Lymphoma cells, FL-1at 2 ug/mL	Mus musculus	15		cell-based format	Scientific Literature
2.	ALA707654	F	Ability to reverse the multidrug resistance (MDR) of mouse Lymphoma cells, FL-1at 20 ug/mL	Mus musculus	13		cell-based format	Scientific Literature
3.	ALA880751	F	Ability to reverse the multidrug resistance (MDR) of mouse Lymphoma cells, by shrinkage (FSC) at 2 ug/mL.	Mus musculus	15		cell-based format	Scientific Literature
4.	ALA707657	F	Ability to reverse the multidrug resistance (MDR) of mouse Lymphoma cells, by shrinkage (FSC) at 20 ug/mL.	Mus musculus	13		cell-based format	Scientific Literature
5.	ALA707660	F	Ability to reverse the multidrug resistance (MDR) of mouse Lymphoma cells, by Granulation (SSC) at 2 ug/mL.	Mus musculus	15		cell-based format	Scientific Literature
6.	ALA707662	F	Ability to reverse the multidrug resistance (MDR) of mouse Lymphoma cells, by Granulation (SSC) at 20 ug/mL.	Mus musculus	13		cell-based format	Scientific Literature
7.	ALA712666	F	Ability to reverse the multidrug resistance (MDR) of mouse Lymphoma cells, fluorescence activity ratio at 2 ug/mL.	Mus musculus	15		cell-based format	Scientific Literature
8.	ALA712667	F	Ability to reverse the multidrug resistance (MDR) of mouse Lymphoma cells, fluorescence activity ratio at 20 ug/mL.	Mus musculus	13		cell-based format	Scientific Literature
9.	ALA1816691	F	Antiproliferative activity against human HeLa cells assessed as growth inhibition at 10 ug/mL after 72 hrs by MTT assay	Homo sapiens	14		cell-based format	Scientific Literature
10.	ALA1816692	F	Antiproliferative activity against human Ishikawa cells assessed as growth inhibition at 10 ug/mL after 72 hrs by MTT assay	Homo sapiens	14		cell-based format	Scientific Literature
11.	ALA1816693	F	Antiproliferative activity against human MCF7 cells assessed as growth inhibition at 10 ug/mL after 72 hrs by MTT assay	Homo sapiens	14		cell-based format	Scientific Literature
12.	ALA1816694	F	Antiproliferative activity against human HeLa cells assessed as growth inhibition at 30 ug/mL after 72 hrs by MTT assay	Homo sapiens	14		cell-based format	Scientific Literature
13.	ALA1816797	F	Antiproliferative activity against human Ishikawa cells assessed as growth inhibition at 30 ug/mL after 72 hrs by MTT assay	Homo sapiens	14		cell-based format	Scientific Literature
14.	ALA1816798	F	Antiproliferative activity against human MCF7 cells assessed as growth inhibition at 30 ug/mL after 72 hrs by MTT assay	Homo sapiens	14		cell-based format	Scientific Literature
15.	ALA1816799	B	Inhibition of MDR1-mediated rhodamine 123 uptake expressed in mouse L5178Y cells transfected with pHa MDR1/A assessed as fluorescence activity ratio at 4 ug/mL by flow cytometry relative to untreated control		13		cell-based format	Scientific Literature
16.	ALA1816800	B	Inhibition of MDR1-mediated rhodamine 123 uptake expressed in mouse L5178Y cells transfected with pHa MDR1/A assessed as fluorescence activity ratio at 40 ug/mL by flow cytometry relative to untreated control		13		cell-based format	Scientific Literature
17.	ALA4042015	B	Activation of PKC in human platelet assessed as induction of platelet aggregation at 10 uM measured within 15 mins by tribidimetric method	Homo sapiens	3		assay format	Scientific Literature
18.	ALA4042018	B	Activation of PKC in human platelet assessed as increase in platelet secretion by measuring ATP release at 10 uM measured after 5 mins by luciferin-luciferase assay	Homo sapiens	6		assay format	Scientific Literature
19.	ALA4042055	B	Activation of PKC in human platelet assessed as phosphorylation of PKC substrates at 10 uM measured after 10 mins by Western blot analysis	Homo sapiens	6		assay format	Scientific Literature